| An integrated map of genetic variation from 1,092 human genomes | Nature | 2012 | 6K |
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Integrin signaling | Science | 1999 | 3.8K |
| Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Nature | 1984 | 3.2K |
| Systematic functional analysis of the Caenorhabditis elegans genome using RNAi | Nature | 2003 | 2.8K |
| Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq | Nature | 2012 | 2.4K |
| Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Journal of Clinical Oncology | 2003 | 2.3K |
| Bcl-2 and the regulation of programmed cell death | Journal of Cell Biology | 1994 | 2.1K |
| Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model | Science | 1998 | 1.7K |
| Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions | Nature | 2005 | 1.7K |
| Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo | Oncogene | 1994 | 1.5K |
| Mass spectrometry-based metabolomics | Mass Spectrometry Reviews | 2007 | 1.4K |
| EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013 | European Urology | 2014 | 1.4K |
| Integrins | Journal of Clinical Investigation | 1991 | 1.4K |
| Negative regulation of transforming growth factor-beta by the proteoglycan decorin | Nature | 1990 | 1.4K |
| Arg-Gly-Asp: a versatile cell recognition signal | Cell | 1986 | 1.3K |
| Nanocrystal targeting in vivo | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 1.2K |
| Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil | Journal of Clinical Oncology | 2009 | 1.2K |
| Fibronectin and its receptors | Annual Review of Biochemistry | 1988 | 1.2K |
| Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis | Immunity | 2014 | 1.2K |
| A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes | Nature Genetics | 2004 | 1.1K |
| EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer | European Urology | 2014 | 965 |
| Anchorage dependence, integrins, and apoptosis | Cell | 1994 | 940 |
| Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1 | Nature | 1990 | 908 |
| Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease | Nature | 1992 | 906 |
